Pricing Log in Create free account

Editas Medicine, Inc. (EDIT) vs Zura Bio Limited (ZURA)

Editas Medicine, Inc. and Zura Bio Limited are both Biotechnology companies. Editas Medicine, Inc. and Zura Bio Limited are of similar size ($399.3M and $384.3M). Zura Bio Limited has the higher net margin (0.00% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zura Bio Limited leads on 8 and Editas Medicine, Inc. on 3.

Valuation

Metric EDIT ZURA Biotechnology median
P/E n/m n/m 10.64
P/S 6.60 n/m 9.59
P/B 2.95 2.86 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 2.79 n/m 9.45
Earnings yield (28.85%) (28.20%) (34.69%)
Free cash flow yield (38.78%) (17.05%) (24.02%)

Profitability

Metric EDIT ZURA Biotechnology median
Gross margin 100.00% — 65.59%
Operating margin (161.39%) 0.00% 0.00%
Net margin (157.32%) 0.00% 0.00%
Free cash flow margin (255.88%) 0.00% 0.00%
Return on equity (118.82%) (85.05%) (51.96%)
Return on assets (33.02%) (72.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDIT ZURA Biotechnology median
Revenue growth (TTM) 20.83% — 4.59%
EPS growth (last fiscal year) 37.50% (76.67%) 29.88%
Revenue growth, 5-year CAGR (14.89%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 11.29 4.86
Net debt to EBITDA 0.94 1.45 1.01

Dividend

Metric EDIT ZURA Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric EDIT ZURA Biotechnology median
Market cap 399.31m 384.34m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack